Author pages are created from data sourced from our academic publisher partnerships and public sources.
Focusing on the preventability of adverse drug reactions.
Pure red-cell aplasia and epoetin therapy.
- C. Bennett, S. Luminari, +15 authors N. Casadevall
- The New England journal of medicine
- 30 September 2004
BACKGROUND Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone treatment with recombinant human erythropoietin (epoetin). Between 1998… Expand
The financial burden of cancer: estimates from a study of insured women with breast cancer.
- A. Arozullah, E. Calhoun, +6 authors C. L. Bennett
- The journal of supportive oncology
- 1 May 2004
The financial impact of cancer can be large, even among persons with comprehensive health insurance policies. Prior studies have found that women with cancer are especially likely to suffer financial… Expand
Factors that Influence Prescribing Decisions
BACKGROUND Strategies to control the quality and cost of medication use are largely dependent on the ability to alter selection of medications. Previous models of prescribing behavior have focused on… Expand
National trends in prescription drug expenditures and projections for 2017.
- G. Schumock, E. Li, +5 authors L. Vermeulen
- American journal of health-system pharmacy : AJHP…
- 1 May 2017
PURPOSE Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, and projections are made for drug spending in 2017 in nonfederal hospitals, clinics, and… Expand
Guidelines for Acute Decompensated Heart Failure Treatment
- R. Didomenico, Hayley Y. Park, +4 authors G. Schumock
- The Annals of pharmacotherapy
- 1 April 2004
OBJECTIVE To describe the development of guidelines for the treatment of acute decompensated heart failure (ADHF) in the emergency department/observation unit (ED-OU) setting for hospitals that are… Expand
Prioritizing Future Research on Off‐Label Prescribing: Results of a Quantitative Evaluation
- S. Walton, G. Schumock, Ky-Van Lee, G. Alexander, D. Meltzer, R. Stafford
- 1 December 2008
Study Objective. To develop a prioritized list of individual drugs for which future research regarding off‐label uses is warranted.
Evidence of the Economic Benefit of Clinical Pharmacy Services: 1996–2000
- G. Schumock, Melissa G Butler, P. Meek, L. Vermeulen, B. Arondekar, J. Bauman
- 1 January 2003
We sought to summarize and assess original evaluations of the economic impact of clinical pharmacy services published from 1996–2000, and to provide recommendations and methodologic considerations… Expand
The Research on Adverse Drug Events and Reports (RADAR) project.
CONTEXT In 1998, a multidisciplinary team of investigators initiated RADAR (Research on Adverse Drug events And Reports), a clinically based postmarketing surveillance program that systematically… Expand
Economic Evaluations of Clinical Pharmacy Services: 2001–2005
The objectives of this review were to summarize and evaluate studies that measured the economic impact of clinical pharmacy services published between 2001 and 2005 (inclusive) and to provide… Expand